CONSENT OF NORTON ROSE CANADA LLP We hereby consent to the use of our name in the prospectus supplement filed by Oncolytics Biotech Inc. on

CONSENT OF NORTON ROSE CANADA LLP

We hereby consent to the use of our name in the

prospectus supplement filed by Oncolytics Biotech Inc. on February 20, 2013 under the headings Certain Canadian Federal Income Tax Considerations and Legal Matters and to the reference to our opinion under the heading

Certain Canadian Federal Income Tax Considerations. In giving such consent we do not thereby admit that we are in the category of persons whose consent is required under Section 7 of the United States Securities Act of 1933, as

Date: February 20, 2013